Gut microbiota-derived acetate attenuates lung injury induced by influenza infection via protecting airway tight junctions.

Collectively, our results demonstrated that GM protected airway TJs by modulating GPR43-AMPK signaling in IAV-induced lung injury. Therefore, improving GM dysbiosis may be a potential therapeutic target for patients with IAV infection.